Histone H3.3 Mutations: A Variant Path to Cancer
- 1 November 2013
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 24 (5) , 567-574
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomasActa Neuropathologica, 2013
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasActa Neuropathologica, 2012
- A Developmental Requirement for HIRA-Dependent H3.3 Deposition Revealed at Gastrulation in XenopusCell Reports, 2012
- Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYCCancer Cell, 2012
- Association of Age at Diagnosis and Genetic Mutations in Patients With NeuroblastomaJAMA, 2012
- Dynamics of Histone H3 Deposition In Vivo Reveal a Nucleosome Gap-Filling Mechanism for H3.3 to Maintain Chromatin IntegrityMolecular Cell, 2011
- The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant GliomaCancer Cell, 2011
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Transcriptional and Developmental Functions of the H3.3 Histone Variant in DrosophilaCurrent Biology, 2009
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing PluripotencyMolecular Cell, 2008